Oura’s Potential IPO: What the $3 Billion Smart-Ring Deal Could Mean

Oura Health Oy is reportedly weighing a U.S. initial public offering that could raise up to $3 billion and value the smart-ring maker at more than $16 billion. The listing could happen as soon as September, although the proposed size, valuation, timing, and share structure remain subject to change. 117

The most important distinction is that the reported $3 billion would not necessarily represent new money for Oura. Existing backers are expected to sell a significant amount of stock alongside any shares offered by the company, making the transaction both a potential capital raise and a liquidity event for early investors. 117

What is known about the potential Oura IPO?

• Target proceeds: Up to $3 billion, according to reporting citing people familiar with the plans. 117
• Potential valuation: More than $16 billion. 117
• Possible timing: As soon as September, though no final date has been announced. 117
• Existing investors: Backers are expected to sell a substantial portion of the shares in the offering. 117
• Public filing status: Oura confirmed on May 21 that it had confidentially submitted a draft registration statement to the U.S. Securities and Exchange Commission. 1
• Reported banks: Goldman Sachs, Morgan Stanley, JPMorgan Chase, Allen & Co., and Jefferies have been linked to the proposed offering. 915

A confidential filing allows a company to begin SEC review before publicly disclosing the full prospectus. At this stage, Oura has not set or disclosed the final number of shares or the price range. 19

The valuation jump is the central investor question

Oura was valued at about $11 billion after its $875 million Series E financing in 2025. Some reports describe the private-market mark as approximately $10.9 billion, but the sources consistently place it at roughly $11 billion. 2316

A public valuation above $16 billion would therefore represent a substantial increase from the last private financing. That comparison is not the same as an IPO return calculation: the eventual public price will depend on the number of shares issued, the shares sold by existing holders, dilution, and the final terms disclosed in the prospectus.

For investors, the proposed pricing would amount to a vote on whether Oura deserves to be valued as more than a premium wearable-device company. The case would likely depend on continued device demand, recurring membership revenue, retention, health-data capabilities, and the company’s ability to maintain margins as larger electronics companies enter the market. These are valuation considerations, not disclosed final IPO terms.

Why Oura has an equity story

Oura’s core product is a screen-free smart ring designed to track sleep, activity, and other health metrics while providing personalized wellness insights and guidance. 1

The form factor is central to the company’s positioning. Smart rings are discreet and can be less intrusive than wrist-worn devices during sleep. Their sensors also sit on the finger, where thinner skin and proximity to blood vessels can support physiological measurements, although performance varies by device, metric, and testing conditions.

That gives Oura a focused proposition around sleep and recovery rather than the broader notification, communications, and display features associated with smartwatches. Its opportunity is to turn that focused experience—and the data and software built around it—into a durable consumer-health platform.

Competition is making the timing more consequential

Oura’s lead is facing more direct pressure. Samsung’s Galaxy Ring brings a major mobile-device ecosystem into the category, while its approach can reduce the appeal of paying a separate subscription for certain health information in at least some markets. 14

Apple has also been reported as exploring a competing smart ring, although the available reporting does not establish a product launch, price, or release date.

The competitive threat is not limited to hardware specifications. Samsung and Apple can use existing phones, operating systems, health apps, retail channels, and customer accounts to make a ring part of a wider ecosystem. Oura’s challenge is to persuade customers that its specialized sleep, recovery, and wellness experience is valuable enough to justify its own hardware and membership economics.

What fresh IPO capital could fund

If Oura sells newly issued shares, the proceeds could give it more resources for sensor and software research, clinical validation, marketing, distribution, supply-chain capacity, and partnerships. Those potential uses follow logically from the competitive environment, but they are not a disclosed use-of-proceeds plan. 114

The mix of primary and secondary shares will matter. More primary issuance would direct more capital to Oura but could create greater dilution for existing holders. A larger secondary component would provide liquidity to backers while leaving less of the headline proceeds with the company. The final registration statement and offering documents will be needed to determine that balance.

What to watch before the listing

The reported September window should be treated as a possibility, not a commitment. Investors should look for four concrete updates:

1. The public prospectus: It should provide audited financial statements, revenue and membership information, risk factors, and details of the business model.
2. The share structure: The filing will clarify how many shares Oura and existing investors plan to sell and how much capital the company itself expects to receive.
3. The price range and exchange: Neither has been disclosed at the confidential-filing stage. 19
4. Evidence of competitive resilience: Oura will need to show that its product differentiation and membership model can withstand Samsung’s expansion and any eventual Apple entry.

The proposed Oura IPO is therefore two tests at once. It could provide capital for the company to defend its position in smart rings, while the pricing will test whether public markets accept a valuation far above its last private benchmark. Until Oura publicly discloses the offering terms, the $3 billion target, $16 billion-plus valuation, and September timing remain reported possibilities rather than finalized guidance.